Table 1.
Pathways reported in Fig. 7c | CeDAR | TOAST | TCA | CellDMC | csSAM |
---|---|---|---|---|---|
Phospholipase D signaling pathway | Yes | Yes | Yes | Yes | No |
Wnt signaling pathway | Yes | Yes | No | Yes | No |
Focal adhesion | Yes | Yes | Yes | Yes | No |
EGFR tyrosine kinase inhibitor resistance | Yes | Yes | No | No | No |
Sphingolipid signaling pathway | Yes | No | No | No | No |
Regulation of actin cytoskeleton | Yes | Yes | No | Yes | No |
There are six enriched KEGG pathways (with adjusted p-value < 0.2) based on CeDAR uniquely identified csDMCs. We check whether they can be identified by performing the same enrichment analysis on csDMCs identified by TOAST, TCA, CellDMC, and csSAM. In the table, “Yes” means the pathway is enriched by csDMCs reported by corresponding method, while “No” means it is not.